G&CTI – Gene & Cell Therapy Institute, the first independent think tank on gene and cell therapies!

We are pleased to announce our membership as a supporting member of G&CTi – Gene & Cell Therapy Institute, the first independent think tank on gene and cell therapies.

 

We are joining the « Healthcare companies » college and we join the supporting members of G&CTi : Biodimed; Bluebird bio; LHF Espoir; Pfizer; PTC Therapeutics; SFTCG

Gene and cell therapies are promising for rare and severe diseases and will lead to a structural change in our healthcare system. We are convinced that a collective approach with concrete proposals will allow these new therapeutic solutions to emerge.

About G&CTi:

Gene & Cell Therapy Institute (G&CTi) is a free, independent, not-for-profit think tank serving the public interest. Its objective is to bring together all the actors in the French Healthcare sector to become a major player in the democratic debate and to promote the emergence of a long-term vision on advanced therapies.

A balanced, neutral, pluralist, and efficient structure, this think tank is structured around 5 colleges representing all the players in the health sector.

To find out more and join G&CTi, go to www.gcti.fr or send us an email at contact@gcti.fr